The three-dimensional NOGA®(Biologics Delivery Systems, a Johnson & Johnson
company, Irwindale, CA, USA) electromechanical mapping system simultaneously registers …

Injectable scaffolds made of biodegradable biomaterials can stabilize a myocardial infarct
and promote cardiac repair. Here, we describe the synthesis of a new, temperature …

Substantially homogenous cells populations which co-express CD49c, CD90 and
telomerase are made. In one embodiment, humans suffering from a degenerative, traumatic …

Substantially homogenous cells populations which co-express CD49c, CD90 and
telomerase are made. In one embodiment, humans suffering from a degenerative, traumatic …

Background Stem cell transplantation is an emerging therapy for severe cardiomyopathy,
proffering stem cell recruitment, anti-apoptosis, and proangiogenic capabilities. Angiogenic …

A successful potency assay for a cell therapy product (CTP) used in the treatment of
ischemic conditions should quantitatively measure relevant biological properties that predict …

The aim of this study was to evaluate the overexpression of genes central to cell survival and
angiogenesis to enhance the function of human late outgrowth endothelial progenitor cells …

Substantially homogenous cells populations which co-ex press CD49c, CD90 and
telomerase are made. In one embodi ment, humans Suffering from a degenerative …

After a myocardial infarction (MI), an increase in the cardiac ratio of matrix
metalloproteinases (MMPs) relative to their inhibitors (TIMPs) causes extracellular matrix …

To determine the efficacy of intramyocardial injection of angiogenic cell precursors in
nonischemic dilated cardiomyopathy, 35 patients with nonischemic dilated cardiomyopathy …